Literature DB >> 27507405

Predictors and Prognostic Significance of Right Ventricular Ejection Fraction in Patients With Ischemic Cardiomyopathy.

Marwa A Sabe1, Sharif A Sabe1, Kenya Kusunose1, Scott D Flamm1, Brian P Griffin1, Deborah H Kwon2.   

Abstract

BACKGROUND: Decreased right ventricular (RV) ejection fraction (RVEF) portends poor prognosis in patients with ischemic cardiomyopathy, and previous studies have suggested an association between mitral regurgitation (MR) and RVEF. We sought to evaluate this association and whether mitral valve repair or replacement affects the relationship between RV function and mortality.
METHODS: We included 588 patients (mean age, 63±11 years; 75% male) with ischemic cardiomyopathy who underwent cardiac magnetic resonance imaging between 2002 and 2008. Baseline characteristics, left ventricular ejection fraction, MR severity, treatment modality, scar burden, and RVEF were assessed. Multivariable linear regression and Cox proportional hazards models were used to assess the association between MR and RVEF and between RVEF and mortality, respectively.
RESULTS: After adjustment for age, sex, left ventricular ejection fraction, right bundle-branch block, and RV scar, MR severity was found to be associated independently with RVEF. There were a total of 240 deaths during a median follow-up time of 5.7 years. After multivariable adjustment, every 10% decrease in RVEF was associated with a 17% increased risk of death (P=0.008). Although decreasing RVEF was associated with a poor prognosis in the nonrepair group (hazard ratio, 1.28; 95% confidence interval, 1.12-1.47; P<0.001), it was not associated with death in the mitral valve repair or replacement group (P for interaction=0.046).
CONCLUSIONS: MR severity was found to be an independent predictor of RVEF, as were right bundle-branch block, left ventricular ejection fraction, and the presence of RV scar. Decreasing RVEF is associated with increased mortality in patients with ischemic cardiomyopathy; however, this association may be mitigated in patients who undergo mitral valve repair or replacement.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  heart ventricles; ischemic cardiomyopathies; magnetic resonance imaging; mitral valve insufficiency; myocardial infarction

Mesh:

Year:  2016        PMID: 27507405     DOI: 10.1161/CIRCULATIONAHA.116.022339

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Echocardiographic evaluation of the right ventricle: Clinical implications.

Authors:  Tanya Dutta; Wilbert S Aronow
Journal:  Clin Cardiol       Date:  2017-03-14       Impact factor: 2.882

Review 2.  Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

Authors:  Ramya Vajapey; Brendan Eck; Wilson Tang; Deborah H Kwon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-27

3.  Tissue-based markers of right ventricular dysfunction in ischemic mitral regurgitation assessed via stress cardiac magnetic resonance and three-dimensional echocardiography.

Authors:  Jiwon Kim; Javid Alakbarli; Brian Yum; Nathan H Tehrani; Meridith P Pollie; Christiane Abouzeid; Antonino Di Franco; Mark B Ratcliffe; Athena Poppas; Robert A Levine; Richard B Devereux; Jonathan W Weinsaft
Journal:  Int J Cardiovasc Imaging       Date:  2018-11-20       Impact factor: 2.357

4.  Detection and quantitation of right ventricular reversible perfusion defects by stress SPECT myocardial perfusion imaging: A proof-of-principle study.

Authors:  Ayman A Farag; Jack Heo; Lindsey Tauxe; Pradeep Bhambhvani; Guido Germano; Paul Kavanagh; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-07-06       Impact factor: 5.952

Review 5.  Perioperative right ventricular function and dysfunction in adult cardiac surgery-focused review (part 1-anatomy, pathophysiology, and diagnosis).

Authors:  Praveen Kerala Varma; Reshmi Liza Jose; Neethu Krishna; Balaji Srimurugan; George Jose Valooran; Aveek Jayant
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-10-27

6.  Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study.

Authors:  Ashita Barthur; Christine Brezden-Masley; Kim A Connelly; Vinita Dhir; Kelvin K W Chan; Rashida Haq; Anish Kirpalani; Joseph J Barfett; Laura Jimenez-Juan; Gauri R Karur; Djeven P Deva; Andrew T Yan
Journal:  J Cardiovasc Magn Reson       Date:  2017-04-10       Impact factor: 5.364

7.  Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.

Authors:  Shengwei Wang; Hao Cui; Keshan Ji; Changpeng Song; Changwei Ren; Hongchang Guo; Changsheng Zhu; Shuiyun Wang; Yongqiang Lai
Journal:  Cardiovasc Diabetol       Date:  2020-05-13       Impact factor: 9.951

8.  Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease.

Authors:  C Bening; V L Sales; K Alhussini; D Radakovic; R Cris Benitez; N Madrahimov; D Keller; R Leyh
Journal:  BMC Cardiovasc Disord       Date:  2021-03-05       Impact factor: 2.298

9.  Right ventricular functional assessment by three-dimensional transesophageal echocardiography is useful for withdrawal from a right ventricular assist device: a case report.

Authors:  Hiroki Taenaka; Tatsuyuki Imada; Ryuichiro Abe; Akinori Uchiyama; Yuji Fujino
Journal:  JA Clin Rep       Date:  2017-08-15

10.  CD14, CD163, and CCR1 are involved in heart and blood communication in ischemic cardiac diseases.

Authors:  Chengcong Chen; Hong Peng; Yongmei Zeng; Guoqing Dong
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.